Molecular and Entomological Characterization of 2023 Dengue Outbreak in Dhading District, Central Nepal.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
12 Apr 2024
Historique:
received: 12 03 2024
revised: 07 04 2024
accepted: 09 04 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 27 4 2024
Statut: epublish

Résumé

In 2023, Nepal faced its second largest dengue outbreak ever, following a record-breaking number of dengue cases in 2022, characterized by the expansion of infections into areas of higher altitudes. However, the characteristics of the 2023 circulating dengue virus (DENV) and the vector density remain poorly understood. Therefore, we performed DENV serotyping, clinical and laboratory assessment, and entomological analysis of the 2023 outbreak in central Nepal. A total of 396 fever cases in Dhading hospital suspected of being DENV positive were enrolled, and blood samples were collected and tested by different techniques including PCR. Of these, 278 (70.2%) had confirmed DENV infection. Multiple serotypes (DENV-1, -2, and -3) were detected. DENV-2 (97.5%) re-emerged after six years in Dhading while DENV-3 was identified for the first time. Dengue inpatients had significantly higher frequency of anorexia, myalgia, rash, diarrhea, nausea, vomiting, abdominal pain, and thrombocytopenia (

Identifiants

pubmed: 38675935
pii: v16040594
doi: 10.3390/v16040594
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Agency of Medical Research and Development (AMED)
ID : JP223fa627004, JP23fk0108656

Auteurs

Sandesh Rimal (S)

Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.

Sabin Shrestha (S)

Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.

Sunita Wagle Paudel (SW)

Dhading Hospital, Dhading Besi 45100, Nepal.

Yogendra Shah (Y)

Seti Provincial Hospital, Dhangadhi 10900, Nepal.

Govinda Bhandari (G)

Dhading Hospital, Dhading Besi 45100, Nepal.

Kishor Pandey (K)

Central Department of Zoology, Tribhuvan University, Kathmandu 44601, Nepal.

Anjana Kharbuja (A)

Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.

Merveille Kapandji (M)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Ishan Gautam (I)

Natural History Museum, Tribhuvan University, Swayambhu, Kathmandu 44620, Nepal.

Rajshree Bhujel (R)

Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.

Yuki Takamatsu (Y)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Rudramani Bhandari (R)

Dhading Hospital, Dhading Besi 45100, Nepal.

Chonticha Klungthong (C)

Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand.

Sanjaya Kumar Shrestha (SK)

Walter-Reed AFRIMS Research Unit Nepal, Kathmandu 44600, Nepal.

Stefan Fernandez (S)

Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand.

Gathsaurie Neelika Malavige (GN)

Faculty of Medical Sciences, University of Sri Jayewardenepura, Colombo 10250, Sri Lanka.

Basu Dev Pandey (BD)

DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.

Takeshi Urano (T)

DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.

Kouichi Morita (K)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.
Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, Japan.
Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Mya Myat Ngwe Tun (MM)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.
Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, Japan.
Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Shyam Prakash Dumre (SP)

Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH